1. Signaling Pathways
  2. Apoptosis
  3. RIP kinase

RIP kinase (受体相互作用蛋白激酶)

Receptor interacting protein 2 (RIP2), a serine/threonine kinase, is an adaptor molecule of NOD1 and NOD2, and genetic variation in this receptor is known to be associated with the severity of allergic asthma in children.

Receptor interacting protein kinase 2 (RIPK2) is critical for NOD-mediated NF-κB activation and cytokine production. WEHI-345, a selective RIPK2 kinase inhibitor, which delays RIPK2 ubiquitylation and NF-κB activation downstream of NOD engagement.

Receptor interacting protein kinase 3 (RIPK3) is a cytosolic master regulator of necroptosis. RIPK3 has an active serine/threonine kinase domain at the N-terminus, and a unique protein-protein interaction domain called the RIP homotypic interaction motif (RHIM) at the C-terminus. Both kinase activity and RHIM are indispensable for necroptosis. RIPK3 interacts with other RHIM-containing proteins such as RIPK1, Toll/interleukin-1 (IL-1) receptor domain-containing adaptor protein inducing TRIF or DAI. RIPK3 induces necroptosis, a type of regulated necrosis, through its kinase domain and RHIM.

RIP kinase 相关产品 (13):

Cat. No. Product Name Effect Purity
  • HY-15760
    Necrostatin-1 Inhibitor 99.87%
    Necrostatin-1 (Nec-1) 是一种有效的坏死性凋亡 (necroptosis) 抑制剂,在 Jurkat 细胞中的 EC50 为 490 nM。Necrostatin-1 抑制 RIP1 激酶 (EC50=182 nM) 。Necrostatin-1 (Nec-1) 也是一种 (IDO) 抑制剂。
  • HY-101872
    GSK-872 Inhibitor 99.91%
    GSK-872 是 RIPK3 抑制剂,高亲和力结合 RIP3 激酶结构域,IC50为1.8 nM,并抑制激酶活性,IC50为1.3 nM。
  • HY-100339
    GSK583 Inhibitor 98.64%
    GSK583 是一种高效、口服有效的、高选择性的 RIP2 Kinase 抑制剂,其 IC50 值为 5 nM。GSK583 可同时抑制TNF-α 和IL-6 的产生,IC50 值为 200 nM。
  • HY-114349
    HS-1371 Inhibitor 98.49%
    HS-1371是高效,ATP-competitive的受体相互作用蛋白3 (RIP3)抑制剂,IC50 为 20.8 nM。
  • HY-125402
    GSK-843 Inhibitor >98.0%
    GSK-843 (GSK'843) 是一种受体相互作用蛋白激酶 3 (RIP3 or RIPK3) 抑制剂,高亲和力结合 RIP3 激酶结构域,IC50 值为 8.6 nM,并抑制激酶活性,IC50 值为 6.5 nM。
  • HY-104021
    GSK840 Inhibitor 98.02%
    GSK840 (GSK'840) 是一种受体相互作用蛋白激酶 3 (RIP3 或 RIPK3) 抑制剂,高亲和力结合 RIP3 激酶结构域,IC50 值为 0.9 nM,并抑制激酶活性,IC50 值为 0.3 nM。
  • HY-19761
    RIP2 kinase inhibitor 2 Inhibitor 99.95%
    RIP2 kinase inhibitor 2 是一种受体相互作用蛋白-2 (RIP2) 激酶抑制剂,详细信息请参考专利 WO/2014043437 A1 中的化合物 example 9。
  • HY-18901
    RIPK1-IN-4 Inhibitor 98.22%
    RIPK1-IN-4 (compound 8) 是一种有效的 II 型激酶受体相互作用蛋白1 (RIP1) 激酶抑制剂,并且与 DL1-out 无活性形式的 RIP1 结合,对于 RIP1 和 ADP-Glo 激酶,IC50 为分别为 16 nM 和 10 nM。
  • HY-107978
    RIPK-IN-4 Inhibitor 99.35%
    RIPK-IN-4 是一种有效选择性的、具有良好的口服生物利用度的 RIPK2 抑制剂,IC50 值为 3 nM。
  • HY-119933
    RIPK1-IN-7 Inhibitor 98.27%
    RIPK1-IN-7 是受体相互作用蛋白激酶 1 (RIPK1) 抑制剂,Kd 值为 4 nM,IC50 值为 11 nM。RIPK1-IN-7 在 实验性 B16 黑色素瘤肺转移模型中具有良好的抗转移活性。
  • HY-N3417
    Kongensin A Inhibitor >98.0%
    Kongensin A 是一种从 Croton kongensis 中分离的天然产物。 Kongensin A 是一种有效的,共价的 HSP90 抑制剂,可阻断 RIP3 依赖性坏死病。Kongensin A 是一种有效的坏死性抑制剂和凋亡诱导剂,并具有潜在的抗坏死性和消炎性应用。
  • HY-128585
    GNE684 Inhibitor
    GNE684 是一种有效的受体相互作用蛋白 1 (RIP1) 抑制剂,作用于人类、小鼠与大鼠 RIP1 的 Kiapp 值分别为 21 nM、189 nM 和 691 nM。
  • HY-125466
    cRIPGBM 是RIPGBM 的促凋亡衍生物,是通过与受体相互作用蛋白激酶2 (RIPK2)结合,诱导 GBM 肿瘤干细胞 凋亡的选择性诱导剂,对 GBM-1 细胞的 EC50 值为 68 nM。
Isoform Specific Products

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.